ALIM Past Earnings image   This ALIM past earnings page last updated 7/29/2022
ALIM Past Earnings
PeriodPast Earnings DateGAAP
Q2 20227/27/2022-0.450
Q1 20225/9/2022-0.850
Q4 20212/24/2022-0.590
Q3 202110/28/2021-0.600
Q2 20218/13/20210.720
Q1 20214/28/2021-0.630
Q4 20202/24/2021-0.180
Q3 202010/28/2020-0.120
Q2 20207/29/2020-0.510
Q1 20204/29/2020-0.240
Q4 20192/26/20200.080
Q3 201910/29/2019-0.600
Q2 20197/29/2019-1.050
Q1 20194/29/2019-0.600
Q4 20182/18/2019-0.300
Q3 201811/5/2018-0.750
Q2 20187/30/2018-0.900
Q1 20185/2/2018-1.650
Q4 20172/28/2018-1.500
Q3 201711/1/2017-0.600
Q2 20178/2/2017-0.600
Q1 20175/8/2017-1.500
Q4 20163/1/2017-1.500
Q3 201611/2/2016-2.250
Q2 20168/3/2016-2.550
Q1 20165/4/2016-3.300
Q4 20153/2/2016-3.600
Q3 201511/5/2015-3.150
Q2 20158/10/2015-3.750
Q1 20155/7/2015-4.050
Q4 20143/4/2015-4.200
Q3 201411/6/2014-3.300
Q2 20148/7/2014-2.400
Q1 20145/8/2014-3.000
Q4 20132/27/2014-3.600
Q3 201311/11/2013-0.600
Q2 20138/12/2013-10.050
Q1 20135/9/2013-4.050
Q4 20123/21/2013-2.550
Q3 201211/7/2012-2.550
ALIM Past Revenue
PeriodPast Earnings DateGAAP
Q2 20227/27/20220.01B
Q1 20225/9/20220.01B
Q4 20212/24/20220.01B
Q3 202110/28/20210.01B
Q2 20218/13/20210.02B
Q1 20214/28/20210.01B
Q4 20202/24/20210.01B
Q3 202010/28/20200.01B
Q2 20207/29/20200.01B
Q1 20204/29/20200.01B
Q4 20192/26/20200.02B
Q3 201910/29/20190.01B
Q2 20197/29/20190.01B
Q1 20194/29/20190.01B
Q4 20182/18/201915.11M
Q3 201811/5/201811.14M
Q2 20187/30/201810.92M
Q1 20185/2/20189.80M
Q4 20172/28/20189.14M
Q3 201711/1/20179.78M
Q2 20178/2/201710.37M
Q1 20175/8/20176.62M
Q4 20163/1/201710.68M
Q3 201611/2/20168.30M
Q2 20168/3/20169.56M
Q1 20165/4/20165.80M
Q4 20153/2/20165.82M
Q3 201511/5/20156.90M
Q2 20158/10/20155.78M
Q1 20155/7/20153.94M
Q4 20143/4/20151.74M
Q3 201411/6/20142.41M
Q2 20148/7/20142.20M
Q1 20145/8/20142.08M
Q4 20132/27/2014935000
Q3 201311/11/2013758000
Q2 20138/12/20131.79M
Q1 20135/9/2013NA
Q4 20123/21/2013NA
Q3 201211/7/2012NA
Quotes delayed 20 minutes

Email EnvelopeFree ALIM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Alimera Sciences (ALIM) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ALKS Past Earnings
ALLK Past Earnings
ALLO Past Earnings
ALNA Past Earnings
ALNY Past Earnings
ALPN Past Earnings
ALRN Past Earnings
ALT Past Earnings
ALVR Past Earnings
ALXN Past Earnings

ALIM Past Earnings Q&A

What was the best and worst ALIM past earnings results?
For Alimera Sciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ALIM past earnings result in our data set was 0.720/share posted in Q2 2021, while the lowest was in Q2 2013 when ALIM posted -10.050/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2021 when ALIM reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q1 2013 at NA of revenue.

  Suggested answer: There are 40 ALIM past earnings results in our data set.

On this page we presented the ALIM past earnings date information for Alimera Sciences. Reviewing that ALIM Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2021, when ALIM posted gaap of 0.720/share. Meanwhile the lowest ALIM past earnings result was in Q2 2013, when ALIM posted gaap of -10.050/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2021 when ALIM reported 0.02B in revenue, while the smallest revenue quarter was Q1 2013 when ALIM reported NA in revenue.

Any self directed investor doing their due diligence on ALIM or any other given stock can benefit from researching all of the Alimera Sciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Alimera Sciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ALIM. Thanks for visiting, and the next time you need to research ALIM past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding FGI, UPH Options Chain, Top Ten Hedge Funds Holding FFIU.

 

ALIM Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.